What one share of Savara holds
Savara Inc. (together with its subsidiaries “Savara,” the “Company,” “we,” “our” or “us”) is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our sole program, molgramostim inhalation solution ("MOLBREEVI" or "molgramostim"), is an investigational inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor ("GM-CSF") in Phase 3 development for autoimmune pulmonary alveolar proteinosis (“autoimmune PAP”).
Savara’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.58 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.46 |
| Cash and investments | $0.20 |
| Debt | $0.15 |
| Book value | $0.70 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $0.06 | −$9.48 | $0.17 | −$5.10 | — | — |
| 2016 | $0.20 | −$5.62 | $0.00 | −$4.27 | — | −$11.34 |
| 2017 | $0.00 | −$1.76 | $0.03 | −$1.64 | — | $3.91 |
| 2018 | — | −$1.85 | $0.00 | −$1.18 | — | $3.08 |
| 2019 | $0.00 | −$1.95 | $0.00 | −$1.13 | — | $2.00 |
| 2020 | $0.00 | −$0.84 | $0.00 | −$0.67 | — | $1.19 |
| 2021 | — | −$0.32 | $0.00 | −$0.30 | — | $1.27 |
| 2022 | — | −$0.25 | $0.00 | −$0.23 | — | $0.94 |
| 2023 | — | −$0.33 | $0.00 | −$0.31 | — | $1.02 |
| 2024 | — | −$0.48 | $0.00 | −$0.45 | — | $0.99 |
| 2025 | — | −$0.53 | $0.00 | −$0.45 | — | $0.99 |
Common questions about Savara
How much does one share of Savara earn?
Over the last 12 months, Savara lost $0.58 for each share.
Does Savara pay a dividend?
Savara didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Savara’s book value per share?
Savara’s book value is $0.70 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Savara have?
Each share of Savara has $0.20 of cash and investments and $0.15 of debt, as of June 30, 2026.
What is Savara’s free cash flow per share?
−$0.46 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Savara bought back shares?
Savara’s share count rose about 22855% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.